Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05889741 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combining Stellate Ganglion Block With Prolonged Exposure for PTSD

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 1 to 2v8
  2. Primary completion date: Mar 2026 to Mar 31, 2027
    • Study completion date: Aug 2026 to Aug 31, 2027
    v7
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Mar 2024 to Feb 26, 2024
    v6
  4. Start date: Jan 2024 to Mar 2024v5
  5. Start date: Oct 2023 to Jan 2024v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Aug 2023 to Oct 2023v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to compare the combination of Massed Prolonged Exposure (PE); a behavioral therapy for PTSD) and a stellate ganglion block (SGB; an injection of a local anesthetic into the front of the neck) with Massed Prolonged Exposure and a sham injection in a sample of military service members or retirees with PTSD. The main questions it aims to answer are: (1) Does the addition of an SGB improve treatment outcomes associated with Massed PE and (2) Do differences in psychophysiological arousal during the exposure portion of treatment help explain treatment outcomes for PTSD. Participants will receive ten 90-minute session of Massed PE. Between the first and second Massed PE sessions, half of the participants will receive a SGB, and half will receive a sham SGB.
Trial Details
NCT Number NCT05889741
Lead Sponsor The University of Texas Health Science Center at San Antonio
Collaborators: United States Department of Defense
Conditions
(from sponsor)		 Stress Disorders, Post-Traumatic
Related terms Stress Disorders, Post-Traumatic
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov